These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6748393)

  • 1. Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival.
    Sugimachi K; Inokuchi K; Matsuura H; Ueo H; Kumashiro R
    Jpn J Surg; 1984 May; 14(3):217-21. PubMed ID: 6748393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up study of left suprarenal to inferior mesenteric venous shunt for advanced breast cancer.
    Inokuchi K; Nomura Y; Ikejiri T; Kaibara N
    Br J Surg; 1976 Aug; 63(8):639-42. PubMed ID: 953471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
    von Minckwitz G; Puglisi F; Cortes J; Vrdoljak E; Marschner N; Zielinski C; Villanueva C; Romieu G; Lang I; Ciruelos E; De Laurentiis M; Veyret C; de Ducla S; Freudensprung U; Srock S; Gligorov J
    Lancet Oncol; 2014 Oct; 15(11):1269-78. PubMed ID: 25273342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group study.
    Hoogstraten B; Gad-el-Mawla N; Maloney TR; Fletcher WS; Vaughn CB; Tranum BL; Athens JW; Costanzi JJ; Foulkes M
    Cancer; 1984 Nov; 54(10):2248-56. PubMed ID: 6488144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.
    Morimoto T; Ogawa M; Orita K; Sugimachi K; Toge T; Dohi K; Nomura Y; Monden Y; Ogawa N
    Eur J Cancer; 1996 Feb; 32A(2):235-42. PubMed ID: 8664034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
    Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
    Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic principle in terminal breast cancer-with reference to hormone-conditioned cancer chemotherapy].
    Inokuchi K; Hattori T; Kimura N; Nomura Y; Takada N
    Shujutsu; 1967 Sep; 21(9):883-93. PubMed ID: 5592178
    [No Abstract]   [Full Text] [Related]  

  • 10. XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.
    Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
    Anticancer Res; 2014 Jun; 34(6):3031-7. PubMed ID: 24922669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H; van Kampen M
    Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
    Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D
    Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study on breast conservative surgery plus chemo- and radiotherapy in treating Chinese patients with early staged breast cancer.
    Liu YC; Zhou SB; Gao F; Yin XX; Zhao Y; Huang XE
    Asian Pac J Cancer Prev; 2013; 14(6):3747-50. PubMed ID: 23886176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
    Zielinski C; Láng I; Inbar M; Kahán Z; Greil R; Beslija S; Stemmer SM; Zvirbule Z; Steger GG; Melichar B; Pienkowski T; Sirbu D; Petruzelka L; Eniu A; Nisenbaum B; Dank M; Anghel R; Messinger D; Brodowicz T;
    Lancet Oncol; 2016 Sep; 17(9):1230-9. PubMed ID: 27501767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and hormone therapy of metastatic breast cancer.
    Paterson AH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
    [No Abstract]   [Full Text] [Related]  

  • 17. Salvage treatments in relapsing resectable breast cancer.
    Valagussa P; Brambilla C; Zambetti M; Bonadonna G
    Recent Results Cancer Res; 1989; 115():69-76. PubMed ID: 2696043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment guideline for advanced or recurrent breast cancer].
    Watanabe T; Katsumata N; Saijo N
    Nihon Rinsho; 2000 Apr; 58 Suppl():237-45. PubMed ID: 11026001
    [No Abstract]   [Full Text] [Related]  

  • 19. Suprarenal-inferior mesenteric venous shunt for advanced carcinoma of the breast.
    Inokuchi K; Ikejiri T
    Arch Surg; 1966 Jun; 92(6):853-6. PubMed ID: 5933253
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of locoregional recurrent breast cancer.
    Janjan NA; McNeese MD; Buzdar AU; Montague ED; Oswald MJ
    Cancer; 1986 Oct; 58(7):1552-6. PubMed ID: 3755648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.